Table 2.
Clinical grade | HTAAD genes panel | Protein | %-pathogenic varianta | Syndrome |
---|---|---|---|---|
CAT A1/A2 definitive/ strong |
ACTA2 | Smooth muscle alpha 2 actin | + + + | Multiple SMC dysfunction syndrome |
COL3A1 | Collagen alpha 1(III) chain | + + + | Ehlers-Danlos syndrome type IV | |
FBN1 | Fibrillin-1 | + + + | Marfan syndrome | |
SMAD3 | SMAD family member 3 | + + + | Loeys-Dietz, aneurysms osteoarthritis syndrome | |
TGFβ2 | Transforming growth factor beta-2 | + + + | Loeys-Dietz syndrome | |
TGFBR1 | Transforming growth factor beta receptor 1 | + + + | Loeys-Dietz syndrome | |
MYH11 | Smooth muscle-myosin heavy chain 11 | + + + | Familial aortic aneurysm | |
MYLK | Myosin light chain kinase | + + + | Familial aortic aneurysm | |
LOX | Lysyl oxidase | + + | Not yet classified | |
PRKG1 | Protein kinase, cGMP-dependent 1 | + + | Familial aortic aneurysm | |
EFEMP2 | Fibulin 4 | + + | Cutis laxa type Ib | |
CAT B moderate/ limited |
ELN | Tropoelastin | + | Cutis laxa, Williams Syndrome |
FBN2 | Fibrillin-2 | + + + | Congenital contractural archnodactyly | |
FLNA | Filamin A | + + | Periventricular nodular heterotopia | |
NOTCH1 | Notch1 | + + | BAV with aneurysm | |
SLC2A10 | Glucose transporter protein type 10 | + + + | Arterial tortuosity syndrome | |
SMAD4 | SMAD family member 4 | + + | JP/HHT syndrome | |
SKI | SKI proto-oncogene | + + + | Shprintzen-Goldberg syndrome | |
TGFB3 | Transforming growth factor beta-3 | + + | Loeys-Dietz syndrome | |
Undetermined | BGN | Small leucine-rich proteoglycan | + + | Meester-loeys syndrome |
FOXE3 | Forkhead box E3 | + + | Familial aortic aneurysm | |
MAT2A | Methionine adenosyltransferase IIA | + + | Familial aortic aneurysm | |
MFAP2 | Microfibril-associated protein 2 | + + | Familial aortic aneurysm | |
SMAD2 | SMAD family member 2 | + | Not yet classified |
a%- pathogenic variant: ( +) 1–25%; (+ +) 26–75%; (+ + +) 75–100%